About Us

Who We Are

Infinite Biomedical Technologies, LLC (IBT) is a medical device company dedicated to creating solutions for the clinical care and research settings.

Our vision is to solve important clinical problems by translating our research discoveries into medical products through commercialization.

Our mission is to become the leading supplier of innovative instrumentation, analytical software, and services for neurodiagnostics.

What We Do

We develop neurodiagnostic monitoring technologies for timely and accurate brain assessment of patients in the ICU, ER, and EMS environments.

Our solutions provide a quantitative evaluation of EEG via advanced signal processing. These products are intuitive and allow for rapid feedback where none was previously available (i.e. neurological status for the non-neurologist) and lead to potential cost savings to providers.

We target the following scenarios with plans to expand into other related application areas:

•Neurologic monitoring in the ICU

•Seizure screening in the ED and EMS settings

Management Team

Santosh Venkatesha, MBA
Chief Executive Officer

Santosh Venkatesha has grown the company to over $20M in NIH SBIR funding since launching his career in 1999. He has led the commercialization effort to establish the company’s first revenue-generating contracts with local hospitals in 2008. In addition, he holds 3 patents in the field of neurodiagnostics. Mr. Venkatesha received his BSE in Biomedical Engineering from Duke University in 1999 and his MBA from The Wharton School University of Pennsylvania in 2007.

Ananth Natarajan, MD
Founder

Dr. Natarajan is a physician-entrepreneur who specializes in utilization of advanced technology to solve pressing clinical problems. He co-founded Infinite Biomedical Technologies (IBT) in 1997 and was the CEO of the company until 2008. Funding for the company has been provided by the National Institutes of Health, which committed substantial capital to IBT for development of its high-risk, high-reward technologies. For the past several years, he has also been an active angel investor and has helped fund over a half-dozen early stage technology companies.

Ananth has several publications, presentations, and patents to his credit. He has received the TR100 award from Massachusetts Institute of Technology’s Technology Review and the 2009 Duke University Engineering Distinguished Young Alumnus Award. Red Herring magazine has cited him as one of “5 Technology Innovators Changing the World.” He is a member of Annandale Golf Club, the California Club, the Caltech Associates, the Economic Round Table, the Huntington Society of Fellows, the Pasadena Angels and the Tech Coast Angels. He also serves on the Board of Directors of Ikona Medical Corporation, the Pasadena Angels and the Caltech Associates. He is Past President of the Physicians’ Wine & Food Society and continues to serve on its Executive Committee.

Dr. Natarajan received his BSE in Biomedical Engineering and Electrical Engineering from Duke University (at age 18, with Distinction). He received an MSE in Biomedical Engineering from Johns Hopkins University and his MD from the University Of Chicago Pritzker School of Medicine. Additionally, he completed his residency training in Obstetrics & Gynecology at the University of Southern California, where he currently serves as Associate Professor of Clinical Obstetrics & Gynecology.

Nitish Thakor, PhD
Chief Scientific Advisor & Founder

Nitish Thakor is a Professor of Biomedical Engineering and Director of Biomedical Instrumentation at Johns Hopkins University. He currently serves on the editorial boards of several journals including IEEE Transactions on Biomedical Engineering, IEEE Transactions on Information Technology in Biomedicine, and the Annals of Biomedical Engineering.